Ronaldo Bioniq Investment: Footballers as Brand Strategy

Cristiano Ronaldo invested in Bioniq, a London company that makes personalized supplements from blood test data, in autumn 2024, lifting its valuation to $82 million. Manchester United's Diogo Dalot followed in March 2025 with more than €1 million. Both were customers first, and Bioniq has used their names heavily in its marketing, which makes it a clear example of the celebrity investor as brand strategy.

Figures come from company announcements and trade coverage by Business Wire, UKTech.news, Tech.eu and EU-Startups. Ronaldo's investment amount was not disclosed.

What is Bioniq?

Bioniq is a London company founded in 2019 that makes personalized nutritional supplements based on a customer's blood biomarker data. It describes its products as AI-driven, Swiss-made and pharmaceutical-grade, with precise micro-dosing aimed at individual deficiencies, according to its Business Wire announcements.

According to Bioniq's July 2024 funding announcement, the company raised a $15 million Series B led by the European venture firms HV Capital and Unbound. Silicon Canals reports partnerships with Lanserhof and the UFC, and Bioniq's Business Wire announcements describe a partnership with Truemed, which lets customers use health savings account and flexible spending account funds. UKTech.news reports that its founder and CEO, Vadim Fedotov, played for the German national basketball team.

What did Ronaldo and Dalot invest in Bioniq?

Ronaldo's stake brought Bioniq's total valuation to $82 million, according to the company's announcement. The announcement said he had been a Bioniq member since 2022 and a regular user for nearly three years. Dalot said he discovered Bioniq in 2022. Both announcements present the investors as users who became owners.

How does Bioniq use the footballers in its marketing?

UKTech.news reported in March 2025 that Bioniq has leaned heavily on its connection with Ronaldo in its marketing, with his endorsement featured prominently on its website. The Dalot announcement then gave the company a second sports name and a second round of coverage, about six months after the first, according to Silicon Canals.

Dalot's announcement also tied to a product. Bioniq had launched a hyper-personalized option called Build Your Own, and Dalot described using it to vary his nutrient intake around performance goals.

Why does a celebrity investor work as brand strategy?

Four reasons follow from the public record. This is analysis, not a finding about Bioniq's results.

1. It answers the credibility gap in supplements. Personalized supplements ask buyers to trust unseen testing and dosing. A famous athlete who used the product before investing gives the claim a human proof point.
2. A stake reads as stronger than a fee. An endorsement can be bought. An ownership stake signals the person expects the company to succeed.
3. Each announcement is a news event. The Series B, Ronaldo and Dalot produced three separate funding and endorsement stories in under a year, based on the announcement dates above.
4. The celebrity helps shape the product. Both announcements say the athletes will contribute to product innovation, which gives the marketing a story about the product itself.

What should brands and celebrities disclose?

In the United States, the Federal Trade Commission's endorsement guidance treats an ownership stake as a material connection that should be disclosed clearly when the owner endorses the product. EPR's guide to FTC affiliate disclosure rules covers the broader rules. This article does not assess Bioniq's own disclosures.

A second caution is about how deals are reported. EU-Startups noted in October 2026 that a celebrity's name on a funding round does not mean the celebrity invested the full amount personally. Ronaldo's amount here was not disclosed, and Tech.eu and Endurance.biz reported Dalot's as over €1 million.

What can marketers learn from Bioniq?

1. Start with a real user. Both investors were customers first, which is the strongest version of the story.
2. Disclose the stake wherever the endorsement appears. A website quote from a part owner needs the same clarity as a social post.
3. Stagger the announcements. Spacing the Series B, Ronaldo and Dalot across months created recurring coverage instead of one spike.
4. Tie the name to a product, not just a logo. The Build Your Own launch gave Dalot's involvement a specific subject.

For how Ronaldo's own brand has compounded over time, read the Ronaldo six World Cup case study. For the category, see the supplement marketing guide, 25 best supplement and wellness campaigns and 25 health brand campaigns. For deals between brands and talent, see celebrity marketing agencies compared and the AI Casting Index 2026.